Abstract: The present invention relates to novel derivatives of epirubicin, pharmaceutical composition comprising these derivatives, and uses of epirubicin and its derivative for treating HCV.
Type:
Grant
Filed:
November 14, 2006
Date of Patent:
May 8, 2012
Assignees:
Instytut Biochemii I Biofizyki, Institut National de Las Sante Et de la Recherche Medicale (Inserm), Instytut Medycyny Doswiadczalnej I Kliniczne
Inventors:
Tadeusz Kulikowski, Maria Bretner, Andzelika Najda, Lucyna Cova, Christian Trepo, Ramamurthy Narayan, Andrzej Piasek, Andrzej Lipniacki, Wlodzimierz Zagorski-Ostoja